Ares Financial Consulting’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.8K Hold
829
0.03% 239
2026
Q1
$51.2K Buy
829
+378
+84% +$22K 0.04% 211
2025
Q4
$24.3K Buy
+451
New +$21.7K 0.02% 237

Other funds holding BMY

Ares Financial Consulting's BMY Position: Q2 2026 in Review

Ares Financial Consulting held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 829 shares worth $47.8K. The position accounts for 0.03% of the portfolio, ranked #239.

Ares Financial Consulting first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $51.2K in Q1 2026. 1,431 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Ares Financial Consulting held 829 shares of Bristol-Myers Squibb worth $47.8K as of Q2 2026.
  • Ares Financial Consulting left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.03% of Ares Financial Consulting's portfolio in Q2 2026, its #239 holding.
  • Ares Financial Consulting first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Ares Financial Consulting's Bristol-Myers Squibb position peaked at $51.2K in Q1 2026.
  • 1,431 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.